Who
David Badawi
Chief Technology Officer
Company insider
Files Form 4 as: Chief Technology Officer, Sight Sciences.
In numbers
- Trades disclosed
- 47
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $588K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Feb 2022
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $71K7,797 at $9.05 | filing |
| 6 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $41K7,418 at $5.51 | filing |
| 6 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $41K7,418 at $5.51 | filing |
| 2 Apr 2026filed 3 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $28K8,168 at $3.48 | filing |
| 2 Apr 2026filed 3 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $28K8,168 at $3.48 | filing |
| 19 Feb 2026filed 23 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code M | $4,89221,270 at $0.23 | filing |
| 19 Feb 2026filed 23 Feb 2026 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —21,270 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —21,270 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code M | $4,89221,270 at $0.23 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —64,915 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —64,915 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $32K4,836 at $6.62 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $32K4,836 at $6.62 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $28K3,695 at $7.48 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $28K3,695 at $7.48 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $24K3,051 at $7.82 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $24K3,051 at $7.82 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $22K2,914 at $7.43 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $22K2,914 at $7.43 | filing |
| 26 Dec 2025filed 30 Dec 2025 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —21,270 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.